CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,349 enrolled
Drug / intervention
Stress cardiac magnetic resonance (CMR) perfusion imagingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03192891
NCT03192891N/ACompleted

Stress CMR Perfusion Imaging in the United States (SPINS) Study. A Society for Cardiovascular Magnetic Resonance (SCMR) Registry Study

Society for Cardiovascular Magnetic Resonance·observational·Posted Jun 20, 2017·Updated Dec 30, 2025

In Brief

An observational study evaluating Stress cardiac magnetic resonance (CMR) perfusion imaging for Myocardial Ischemia. Completed, enrolled 2,349 participants across 13 sites.

Detailed Summary

Numerous single-center studies have indicated gadolinium-enhanced stress CMR perfusion imaging has excellent diagnostic accuracy for coronary artery disease and negative clinical event rates, with its diagnostic accuracy exceeding nuclear scintigraphy. However, current prognostic evidence supporting clinical use of stress CMR is limited by study size, single-center settings with a predominance of academic centers, and a lack of "real-world" study design. Large-scale multicenter real-world evidence from a registry will provide the much needed information to guide evidence-based clinical adaptation that benefits patient care.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 20, 2017
Enrollment StartDec 1, 2016
Primary CompletionNov 30, 2019
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 9.0 years ago

Interventions

Stress cardiac magnetic resonance (CMR) perfusion imagingother

Gadolinium-enhanced stress CMR perfusion imaging is a tool increasingly used for the risk assessment and diagnosis of coronary artery disease.